Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus

Rybelsus (reh-BEL-sus, semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote